We could not find any results for:
Make sure your spelling is correct or try broadening your search.
WESTPORT, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy...
WESTPORT, Conn., March 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy...
WESTPORT, Conn., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG) (“Portage” or the “Company”), a clinical-stage immuno-oncology company advancing novel multi-targeted...
Prioritize the adenosine clinical candidates iNKT clinical development paused to focus resourcesCompany will evaluate range of strategic options WESTPORT, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0453 | -15.8669001751 | 0.2855 | 0.35 | 0.229 | 224490 | 0.27215144 | CS |
4 | -0.3108 | -56.4065335753 | 0.551 | 0.63999 | 0.1999 | 153231 | 0.31504646 | CS |
12 | -0.5598 | -69.975 | 0.8 | 0.8 | 0.1999 | 101170 | 0.43956868 | CS |
26 | -1.6498 | -87.291005291 | 1.89 | 2.17 | 0.1999 | 66699 | 0.68826241 | CS |
52 | -3.0998 | -92.8083832335 | 3.34 | 4.4 | 0.1999 | 42847 | 1.16456859 | CS |
156 | -27.9098 | -99.146714032 | 28.15 | 44.9763 | 0.1999 | 36267 | 8.55801264 | CS |
260 | -37.2598 | -99.3594666667 | 37.5 | 44.9763 | 0.1999 | 35019 | 8.95022577 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions